30|10000|Public
5000|$|Excerpt {{from the}} Kandoian patent:In keeping with {{progress}} {{made during the}} last few years in the development of ultra-high frequency radio technique, and applications thereof to aircraft communication, direction finding, and so forth, it has become necessary to develop special antennas and antenna systems suitable for installation on such aircraft. Flying conditions are such that these antennas must necessarily be small and rigid in their construction and also offer a minimum of wind resistance, in order that the flying efficiency of the aircraft will be unimpaired. In accordance with my invention I have provided a small rigid antenna suitable for mounting {{on the surface of the}} fuselage or other component of the airplane structure and <b>in</b> <b>certain</b> <b>embodiments</b> I have also provided a streamlined protecting shield or housing covering or so cooperating with the construction of the antenna system as to greatly reduce wind resistance.|$|E
40|$|The present {{disclosure}} {{relates to}} the use of a paper medium to measure blood hemoglobin concentration. <b>In</b> <b>certain</b> <b>embodiments,</b> spectrophotometric techniques are used to measure light transmission at specified wavelengths through a paper medium containing a blood sample. The light transmission information is then used in the calculation of blood hemoglobin concentration. <b>In</b> <b>certain</b> <b>embodiments,</b> the paper medium may be chemically treated to lyse the blood sample prior to measurement of the light transmission information...|$|E
40|$|Described herein is {{a method}} of {{treatment}} of cancer or tumor using a modified bacteria or composition comprising the modified bacteria. <b>In</b> <b>certain</b> <b>embodiments,</b> the method is {{in combination with other}} treatment. <b>In</b> <b>certain</b> <b>embodiments,</b> the treatment is chemotherapy, radiation therapy, gene therapy, surgery or a combination thereof. The method makes modified facultative anaerobic bacteria into a conditional obligate anaerobe. The modified bacteria are strictly hypoxia regulated and comprise an essential gene expressing cassette. The vectors of this method comprise the essential gene expressing cassette. Also described herein are therapeutic and prophylactic compositions comprising the modified bacteria. The therapeutic and prophylactic compositions contain a purified form of the modified bacteria, while <b>in</b> <b>certain</b> <b>embodiments,</b> they do not contain other strain of microorganisms. The modified bacteria grow within the solid tumor/cancer, retarding its growth and are rapidly eliminated from normal tissues. The solid tumor/cancer includes breast cancer, liver cancer or neuroblastoma. published_or_final_versio...|$|E
40|$|Recyclable organic {{solar cells}} are {{disclosed}} herein. Systems and methods are further disclosed for producing, improving performance, and for recycling the solar cells. <b>In</b> <b>certain</b> example <b>embodiments,</b> the recyclable organic solar cells disclosed herein include: a first electrode; a second electrode; a photoactive layer disposed {{between the first}} electrode and the second electrode; an interlayer comprising a Lewis basic oligomer or polymer disposed between the photoactive layer {{and at least a}} portion of the first electrode or the second electrode; and a substrate disposed adjacent to the first electrode or the second electrode. The interlayer reduces the work function associated with the first or second electrode. <b>In</b> <b>certain</b> example <b>embodiments,</b> the substrate comprises cellulose nanocrystals that can be recycled. <b>In</b> <b>certain</b> example <b>embodiments,</b> {{one or more of the}} first electrode, the photoactive layer, and the second electrode may be applied by a film transfer lamination method. Georgia Tech Research CorporationPurdue Research FoundationThe United States Of America As Represented By The Secretary Of Agricultur...|$|R
40|$|Novel {{chimeric}} plant promoter sequences are provided, {{together with}} plant gene expression cassettes comprising such sequences. <b>In</b> <b>certain</b> preferred <b>embodiments,</b> the chimeric plant promoters comprise the BoxII cis element and/or derivatives thereof. In addition, novel transcription factors are provided, together with {{nucleic acid sequences}} encoding such transcription factors and plant gene expression cassettes comprising such nucleic acid sequences. <b>In</b> <b>certain</b> preferred <b>embodiments,</b> the novel transcription factors comprise the acidic domain, or fragments thereof, of the RF 2 a transcription factor. Methods for using the chimeric plant promoter sequences and novel transcription factors in regulating the expression {{of at least one}} gene of interest are provided, together with transgenic plants comprising such chimeric plant promoter sequences and novel transcription factors...|$|R
40|$|A {{particle}} cassette for a needleless syringe is provided, {{the manufacture}} of which avoids the potentially detrimental use of heat when affixing a final membrane to the cassette or otherwise sealing the cassette after a filling procedure has been carried out. The particle cassette is assembled using first and second cassette parts that are attachable together so as to create a chamber for the confinement of particles between two membranes. A third cassette part {{may be used to}} provide for a locking attachment of the first and second parts. A kit of parts for use in {{the manufacture of}} a particle cassette is also provided, as is a method of assembling a particle cassette. <b>In</b> <b>certain</b> cassette <b>embodiments,</b> {{one or both of the}} first and second cassette parts can be annular, tapered and/or have detents or recesses to provide for a snap fit...|$|R
40|$|In one embodiment, the {{invention}} provides methods of treatment which use therapeutically effective amounts of Choleste ryl Ester Transfer Protein (CETP) inhibitors to treat a variety of cancers. <b>In</b> <b>certain</b> <b>embodiments,</b> the inhibitor is a CETP-inhibiting small molecule, CETP-inhibiting antisense oligonucleotide, CETP-inhibiting siRNA or a CETP- inhibiting antibody. Related pharmaceutical compositions, kits, diagnostics and screens are also provided...|$|E
40|$|Systems {{and methods}} for {{interference}} cognizant network scheduling are provided. <b>In</b> <b>certain</b> <b>embodiments,</b> {{a method of}} scheduling communications in a network comprises identifying a bin of a global timeline for scheduling an unscheduled virtual link, wherein a bin is {{a segment of the}} timeline; identifying a pre-scheduled virtual link in the bin; and determining if the pre-scheduled and unscheduled virtual links share a port. <b>In</b> <b>certain</b> <b>embodiments,</b> if the unscheduled and pre-scheduled virtual links don't share a port, scheduling transmission of the unscheduled virtual link to overlap with the scheduled transmission of the pre-scheduled virtual link; and if the unscheduled and pre-scheduled virtual links share a port: determining a start time delay for the unscheduled virtual link based on the port; and scheduling transmission of the unscheduled virtual link in the bin based on the start time delay to overlap part of the scheduled transmission of the pre-scheduled virtual link...|$|E
40|$|Compositions {{comprising}} {{a plurality}} of functionalized carbon nanotubes {{and at least one}} type of payload molecule are provided herein. The compositions are soluble in water and PBS in some embodiments. <b>In</b> <b>certain</b> <b>embodiments,</b> the payload molecules are insoluble in water. Methods are described for making the compositions and administering the compositions. An extended release formulation for paclitaxel utilizing functionalized carbon nanotubes is also described...|$|E
40|$|Disclosed herein {{is a novel}} {{antifungal}} compound, derivatives {{that are}} used b treat fungal infections. In a specific embodiment, the compound is a small molecule. In a specific embodiment, the compound described herein inhibits yeast to hypha transition under robust hyphal inducing conditions at lower concentration of the molecule. Also disclosed is a composition comprising the antifungal compound. In a specific embodiment, the composition is a pharmaceutical composition Also {{disclosed is a method}} of treating and/or preventing fungal infection using the disclosed compound. The disclosed compound exhibits antifungal activity against wide range of fungal species at slightly higher concentrations. Antifungal compound disclose d herein is use d as anti-biofilm agent against fungal infections. In a specific embodiment, the disclosed compound is effective for systemic fungal infections. <b>In</b> a <b>certain</b> <b>embodiment,</b> the disclosed compound is a broad-spectrum antifungal agent for treating topical local and/or systemic fungal infections. In a specific embodiment, the disclosed compound is used in the prevention or treatment of mycotic infections caused by various fungal pathogens. published_or_final_versio...|$|R
40|$|A method, system, and {{apparatus}} enables interfering {{signals in}} a communications {{system to be}} efficiently identified using correlation calculations. Once identified, the interfering signals may be rejected and removed from further processing in a receiver. The number of mathematical operations required to determine correlates of multiple training sequences to received sequences (e. g., at multiple offsets) may be reduced by up to eighty percent (80 %) in a Global System for Mobile Communications (GSM) implementation. <b>In</b> accordance with <b>certain</b> <b>embodiments,</b> a correlation equation is manipulated, for example, to eliminate certain products by ensuring that they equate to zero, to eliminate redundant calculations by recognizing repeated subsequences, to eliminate common subexpressions, to determine a negative of a correlation result, etc. The manipulated correlation equation is then utilized within a receiver...|$|R
30|$|All map, combiner, {{and reduce}} stages are {{self-contained}} {{within a single}} user specified map reduction aggregation method allowing access to shared memory between all processing stages. The user specified map reduction aggregation method operates within any number of training and classification worker processes to scale {{as required by the}} user or machine learning task at hand. Strand training worker processes apply map reduction aggregation to gene sequence input data, reducing the resulting minhash signatures and associated classes into the Strand training data structure. <b>In</b> <b>certain</b> Strand <b>embodiments,</b> class frequencies are maintained for each unique minhash key. During classification, minhash values within each minhash signature resulting from map reduction aggregation are looked up within the Strand training data structure to determine an accurate estimation of Jaccard similarity between the query sequence and all known classes. Minhashing is used as a form of lossy compression to reduce the overall size of the training data structure and decrease the processing time required to estimate the similarity between a query sequence and one or more known classes within the system.|$|R
40|$|The present {{invention}} concerns particular biomarkers for diagnosing and/or prognosticating colorectal cancer, {{in particular}} in a non-invasive manner. The methods and compositions concern analysis of methylation patterns {{of one or more}} genes from a set of 29 genes identified as described herein. <b>In</b> <b>certain</b> <b>embodiments,</b> the gene set includes at least P 15. INK 4 b, SST, GAS 7, CNRIP 1, and PIK 3 CG...|$|E
40|$|Methods for {{separating}} magnetic nanoparticles are provided. <b>In</b> <b>certain</b> <b>embodiments,</b> {{a method}} is provided for separating magnetic nanoparticles comprising: providing a sample comprising {{a plurality of}} magnetic nanoparticles; passing the sample through a first magnetic field; at least partially isolating nanoparticles of the first nanoparticle size desired; altering the strength of the first magnetic field to produce a second magnetic field; and at least partially isolating nanoparticles of the second nanoparticle size desired...|$|E
40|$|<b>In</b> <b>certain</b> <b>embodiments</b> of {{the present}} disclosure, a solid oxide fuel cell is described. The solid oxide fuel cell {{includes}} a hierarchically porous cathode support having an impregnated cobaltite cathode deposited thereon, an electrolyte, and an anode support. The anode support includes hydrocarbon oxidation catalyst deposited thereon, wherein the cathode support, electrolyte, and anode support are joined together and wherein the solid oxide fuel cell operates a temperature of 600. degree. C. or less...|$|E
40|$|<b>Certain</b> <b>embodiments</b> are {{directed}} {{to a process}} and apparatus for cleaning and/or regeneration of permeable or semipermeable membranes comprising modulating pressure of a feed stream feeding the permeable or semipermeable membrane and providing intermittent pressure pulses for cleaning and/or regeneration of the permeable or semipermeable membrane...|$|R
40|$|<b>Certain</b> <b>embodiments</b> include {{carbonate}} esters of rapamycin {{at position}} 42 that are synthesized by a lipase catalyzed regio-specific process. These compounds or a pharmaceutically acceptable salt thereof {{are useful in}} the treatment of organ and tissue transplant rejection, autoimmune disease, proliferative disorder, restenosis, cancer, or microbial infection...|$|R
40|$|Materials, {{methods and}} systems are {{provided}} for the purifn., filtration and​/or sepn. of certain mols. such as certain size biomols. <b>Certain</b> <b>embodiments</b> relate to supports contg. at least one polymethacrylate polymer engineered to have certain pore diams. and other properties, and which can be functionally adapted to for certain purifications, filtrations and​/or sepns. Biomols. are selected from a group consisting of: polynucleotide mols., oligonucleotide mols. including antisense oligonucleotide mols. such as antisense RNA and other oligonucleotide mols. that are inhibitory of gene function such as small interfering RNA (siRNA) ​, polypeptides including proteinaceous infective agents such as prions, for example, the infectious agent for CJD, and infectious agents such as viruses and phage...|$|R
40|$|The present {{disclosure}} {{relates to}} devices {{for use in}} conjunction with a syringe in measuring a dose using the syringe. <b>In</b> <b>certain</b> <b>embodiments,</b> a clip is provided that includes an elongated portion for insertion into a barrel of a syringe and a locking portion that locks onto a feature of the syringe. Once inserted, the clip physically prevents retraction of a plunger of the syringe past a certain point corresponding to a desired dose...|$|E
40|$|Apparatus {{and methods}} of {{generating}} magnetization transfer contrast images in which signal to noise ratios are improved and/or in which image acquisition times are reduced. <b>In</b> <b>certain</b> <b>embodiments,</b> apparatus and methods which utilize sensitivity and/or non-sensitivity to magnetization transfer effects to improve the contrast of images which are generated. In certain additional embodiments, apparatus and methods for generating magnetization transfer contrast images which exhibit sensitivity to longitudinal and transverse relaxation times of bound and free proton pools, respectively...|$|E
40|$|Systems {{and methods}} for {{separating}} hydrocarbons on an internal combustion powered vehicle via {{one or more}} metal organic frameworks are disclosed. Systems and methods can further include utilizing separated hydrocarbons and exhaust to generate hydrogen gas for use as fuel. In one aspect, a method for separating hydrocarbons can include contacting a first component containing a first metal organic framework with a flow of hydrocarbons and separating hydrocarbons by size. <b>In</b> <b>certain</b> <b>embodiments,</b> the hydrocarbons can include alkanes...|$|E
40|$|Methods {{and systems}} for aerosol {{delivery}} of agents {{to a patient}} are described herein. The present system {{can be used to}} administer various types of agents, such as a vaccine or other types of pharmaceutical substances. <b>Certain</b> <b>embodiments</b> of the present system utilize an actuator coupled to a disposable aerosolizing element that aerosolizes an agent for delivery to a patient when acted upon by the actuator. The aerosolizing element prevents the agent from contacting the actuator and other non-disposable components of the system so that little or no cleaning or maintenance is required. The present system also can include an aerosolization rate monitor that monitors the rate at which an agent is being aerosolized and provides feedback to the user to ensure that the proper dose is being administered...|$|R
40|$|An optical {{interposer}} {{that includes}} a glass substrate having one or more optical vias extending through the glass substrate. A first optical polymer may be bonded to the substrate and to interior surfaces of {{the one or more}} optical vias. Implementations include one or more optical via cores comprising a second optical polymer that has a greater refractive index than the first optical polymer. The one or more optical via cores may be at least partially surrounded by the first optical polymer. Embodiments include encapsulated optical waveguides in communication with the optical vias and/or via cores. Example implementations include layers of electrical insulation, electrical traces, and electrical vias. A method of manufacture includes forming the optical vias by laser ablation. <b>Certain</b> <b>embodiments</b> may include chemically etching the inside of the vias to improve surface roughness. Georgia Tech Research Corporatio...|$|R
40|$|Methods for remote {{activation}} and permanent or temporary deactivation of integrated circuits (IC) for {{digital rights management}} are disclosed. Remote activation enables designers to remotely control each IC manufactured by an independent silicon foundry. <b>Certain</b> <b>embodiments</b> of the invention exploit inherent unclonable variability in modern manufacturing {{for the creation of}} unique identification (ID) and then integrate the IDs into the circuit functionality. Some of the objectives may be realized by replicating a subset of states of one or more finite state machines and by superimposing additional state transitions that are known only to the designer. On each chip, the added transitions signals are a function of the unique IDs and are thus unclonable. The method and system of the invention is robust against operational and environment conditions, unclonable and attack-resilient, while having a low overhead and a unique key for each IC with very high probability...|$|R
40|$|A {{device and}} related methodologies to deliver {{molecules}} to the cells that comprise any tissues. The invention includes a catheter-based electrode and methods {{for its use}} for the delivery of molecules to cardiac tissue, blood vessels, other tissues/organs that can be accessed through a luminal tissue, and luminal tissues. The invention is also a non-catheter based electrode for performing the same functions. <b>In</b> <b>certain</b> <b>embodiments</b> the electrode utilizes a segmented electrode array wherein each electrode is separately addressable by a source of electricity...|$|E
40|$|Polymers, {{including}} Polyesters and Polycarbonates comprising {{residue of}} bis-furan diol, which is produced from renewable furfural feedstock {{and methods of}} making and using of those polyesters and polycarbonates are described. The method includes reacting a bis-furan diol with a dicarboxylic acid {{in the presence of}} a carbodiimide to produce the bis-furan containing polymers. <b>In</b> <b>certain</b> <b>embodiments,</b> the dicarboxylic acid is succinic acid; the bis-furan diol is the 5, 5 ′-(propane- 2, 2 -diyl) bis(furan- 2, 5 -diyl) dimethanol and the carbodiimide is of N,N-diisopropylcarbodiimide...|$|E
40|$|<b>In</b> <b>certain</b> <b>embodiments,</b> {{the present}} {{invention}} {{is directed to}} a pharmaceutical formulation for topical administration on a mammal, comprising a unit dose of a therapeutically effective amount of a therapeutic agent and a pharmaceutically acceptable carrier medium therefor, said formulation being solid at ambient temperature and having a softening point of not higher than 35 DEG C, such that when the formulation is placed in continuous contact with {{the skin of a}} mammalian patient, it is softened to a consistency to effect substantial application of the unit dose of said therapeutic agent onto a desired skin area of the mammalian patient within a time period of less than 10 minutes...|$|E
40|$|Microcapsules {{prepared}} by encapsulating an aqueous solution of a protein, drug or other bioactive substance inside a semi-permeable membrane by are disclosed. The microcapsules are formed by interfacial coacervation under conditions where the shear forces {{are limited to}} 0 - 100 dynes per sq cm at the interface. By placing the microcapsules in a high osmotic watering solution, the protein solution is gradually made saturated and then supersaturated, and the controlled nucleation and crystallization of the protein is achieved. The crystal-filled microcapsules {{prepared by}} this method can be conveniently harvested and stored while keeping the encapsulated crystals in essentially pristine condition due to the rugged, protective membrane. Because the membrane components themselves are x-ray transparent, large crystal-containing microcapsules can be individually selected. mounted in x-ray capillary tubes and subjected to high energy x-ray diffraction studies to determine the 3 -D structure of the protein molecules. <b>Certain</b> <b>embodiments</b> of the microcapsules of the invention have composite polymeric outer membranes which are somewhat elastic, water insoluble, permeable only to water, salts, and low molecular weight molecules and are structurally stable in fluid shear forces typically encountered in the human vascular system...|$|R
40|$|Previous {{research}} {{works in}} robotics and cognitive science {{have reported that}} humans utilize embodied cooperative behaviors in communication, such as nodding in response to another's it utterance and looking at a <b>certain</b> object <b>in</b> a <b>certain</b> direction as others look or point at. We have developed a humanoid robot that utilizes such an embodied cooperative behavior for natural communication in a route guidance situation. It obtains numerical data on a human's body movement via a motion capturing system and then autonomously selects appropriate cooperative embodiment units from 18 implemented units. Each unit realizes a <b>certain</b> cooperative <b>embodiment</b> behaviors such as eye-contact by using the motion capturing system as well. As {{a result of a}} subject experiment, we have verified the effectiveness of the embodied cooperative behaviors of the robot for reliable and sympathetic communication. Moreover, we analyzed how the auditory expression and the embodiment contributed to the effect...|$|R
5000|$|Alone <b>in</b> <b>certain</b> exclamations or {{elliptical}} sentences, and <b>in</b> <b>certain</b> sentence-modifying expressions: ...|$|R
40|$|Described herein are user-wearable {{devices that}} include an optical sensor, and methods for use therewith. <b>In</b> <b>certain</b> <b>embodiments,</b> an optical sensor of a user-wearable device (e. g., a wrist-worn device) {{is used to}} detect blue light that is {{incident}} on the optical sensor and to produce a blue light detection signal indicative thereof, and thus, indicative of {{the response of the}} user's intrinsically photosensitive Retinal Ganglion Cells (ipRGCs). In dependence on the blue light detection signal, there is a determination of a metric indicative of an amount of blue light detected by the optical sensor. The metric is compared to a corresponding threshold, and a user notification is triggered in dependence on results of the comparing, wherein the user notification informs a person wearing the user-wearable device to adjust their exposure to light...|$|E
40|$|Embodiments {{of solar}} panel {{cleaning}} apparatuses, solar panel cleaning systems, and solar panel cleaning methods are disclosed. <b>In</b> <b>certain</b> <b>embodiments,</b> the disclosed solar panel cleaning apparatuses, systems and methods do may not require any water or other cleaning liquids {{in the whole}} cleaning process, which makes them prominent well suited in for water-deficit environments such as deserts. In one embodiment, the solar panel cleaning apparatus comprises one or more rotatable brushes each having a rotational axis and a drive configured to move each of {{the one or more}} rotatable brushes in a direction that is not perpendicular to the rotational axis. The solar panel cleaning apparatus is may be configured such that the angle of the rotational axis of {{at least one of the}} one or more rotatable brushes is adjustable relative to the direction of travel...|$|E
40|$|Systems {{and methods}} for {{systematic}} hybrid network scheduling for multiple traffic classes with host timing and phase constraints are provided. <b>In</b> <b>certain</b> <b>embodiments,</b> {{a method of}} scheduling communications in a network comprises scheduling transmission of virtual links pertaining to a first traffic class on a global schedule to coordinate transmission of the virtual links pertaining to the first traffic class across all transmitting end stations on the global schedule; and scheduling transmission of each virtual link pertaining to a second traffic class on a local schedule of the respective transmitting end station from which each respective virtual link pertaining to the second traffic class is transmitted such that transmission of each virtual link pertaining to the second traffic class is coordinated only at the respective end station from which each respective virtual link pertaining to the second traffic class is transmitted...|$|E
5000|$|Collection of Information <b>In</b> <b>Certain</b> Circumstances (CIICC): Espanola Police {{call this}} {{practice}} “collection of information <b>in</b> <b>certain</b> circumstances” (CIICC).|$|R
50|$|Bioregionalism, while akin to {{environmentalism}} <b>in</b> <b>certain</b> aspects, such as {{a desire}} to live in harmony with nature, differs <b>in</b> <b>certain</b> ways from classical, 20th century environmentalism.|$|R
50|$|Transnational crimes {{may also}} be crimes of {{customary}} international law or international crimes when committed <b>in</b> <b>certain</b> circumstances. For example, they may <b>in</b> <b>certain</b> situations constitute crimes against humanity.|$|R
